Request for Covid-19 Impact Assessment of this Report
The United States Self-administered Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Self-administered Drugs market, reaching US$ million by the year 2028. As for the Europe Self-administered Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Self-administered Drugs players cover Abbott Laboratories, Bristol-Myers Squibb, Novartis AG, and Eli Lilly and Company, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Self-administered Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Injectable Drugs
Inhaled Drugs
Transdermal Drugs
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Cardiovascular Diseases
Diabetes
Osteoporosis
Pain Management
Hormone Replacement
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Abbott Laboratories
Bristol-Myers Squibb
Novartis AG
Eli Lilly and Company
Gilead Sciences
Antares Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Self-administered Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Self-administered Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Self-administered Drugs by Country/Region, 2017, 2022 & 2028
2.2 Self-administered Drugs Segment by Type
2.2.1 Injectable Drugs
2.2.2 Inhaled Drugs
2.2.3 Transdermal Drugs
2.3 Self-administered Drugs Sales by Type
2.3.1 Global Self-administered Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Self-administered Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Self-administered Drugs Sale Price by Type (2017-2022)
2.4 Self-administered Drugs Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Diabetes
2.4.3 Osteoporosis
2.4.4 Pain Management
2.4.5 Hormone Replacement
2.4.6 Others
2.5 Self-administered Drugs Sales by Application
2.5.1 Global Self-administered Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Self-administered Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Self-administered Drugs Sale Price by Application (2017-2022)
3 Global Self-administered Drugs by Company
3.1 Global Self-administered Drugs Breakdown Data by Company
3.1.1 Global Self-administered Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Self-administered Drugs Sales Market Share by Company (2020-2022)
3.2 Global Self-administered Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Self-administered Drugs Revenue by Company (2020-2022)
3.2.2 Global Self-administered Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Self-administered Drugs Sale Price by Company
3.4 Key Manufacturers Self-administered Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Self-administered Drugs Product Location Distribution
3.4.2 Players Self-administered Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Self-administered Drugs by Geographic Region
4.1 World Historic Self-administered Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Self-administered Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Self-administered Drugs Annual Revenue by Geographic Region
4.2 World Historic Self-administered Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Self-administered Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Self-administered Drugs Annual Revenue by Country/Region
4.3 Americas Self-administered Drugs Sales Growth
4.4 APAC Self-administered Drugs Sales Growth
4.5 Europe Self-administered Drugs Sales Growth
4.6 Middle East & Africa Self-administered Drugs Sales Growth
5 Americas
5.1 Americas Self-administered Drugs Sales by Country
5.1.1 Americas Self-administered Drugs Sales by Country (2017-2022)
5.1.2 Americas Self-administered Drugs Revenue by Country (2017-2022)
5.2 Americas Self-administered Drugs Sales by Type
5.3 Americas Self-administered Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Self-administered Drugs Sales by Region
6.1.1 APAC Self-administered Drugs Sales by Region (2017-2022)
6.1.2 APAC Self-administered Drugs Revenue by Region (2017-2022)
6.2 APAC Self-administered Drugs Sales by Type
6.3 APAC Self-administered Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Self-administered Drugs by Country
7.1.1 Europe Self-administered Drugs Sales by Country (2017-2022)
7.1.2 Europe Self-administered Drugs Revenue by Country (2017-2022)
7.2 Europe Self-administered Drugs Sales by Type
7.3 Europe Self-administered Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Self-administered Drugs by Country
8.1.1 Middle East & Africa Self-administered Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Self-administered Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Self-administered Drugs Sales by Type
8.3 Middle East & Africa Self-administered Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Self-administered Drugs
10.3 Manufacturing Process Analysis of Self-administered Drugs
10.4 Industry Chain Structure of Self-administered Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Self-administered Drugs Distributors
11.3 Self-administered Drugs Customer
12 World Forecast Review for Self-administered Drugs by Geographic Region
12.1 Global Self-administered Drugs Market Size Forecast by Region
12.1.1 Global Self-administered Drugs Forecast by Region (2023-2028)
12.1.2 Global Self-administered Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Self-administered Drugs Forecast by Type
12.7 Global Self-administered Drugs Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Self-administered Drugs Product Offered
13.1.3 Abbott Laboratories Self-administered Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Information
13.2.2 Bristol-Myers Squibb Self-administered Drugs Product Offered
13.2.3 Bristol-Myers Squibb Self-administered Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bristol-Myers Squibb Main Business Overview
13.2.5 Bristol-Myers Squibb Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Self-administered Drugs Product Offered
13.3.3 Novartis AG Self-administered Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Eli Lilly and Company
13.4.1 Eli Lilly and Company Company Information
13.4.2 Eli Lilly and Company Self-administered Drugs Product Offered
13.4.3 Eli Lilly and Company Self-administered Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Eli Lilly and Company Main Business Overview
13.4.5 Eli Lilly and Company Latest Developments
13.5 Gilead Sciences
13.5.1 Gilead Sciences Company Information
13.5.2 Gilead Sciences Self-administered Drugs Product Offered
13.5.3 Gilead Sciences Self-administered Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Gilead Sciences Main Business Overview
13.5.5 Gilead Sciences Latest Developments
13.6 Antares Pharma
13.6.1 Antares Pharma Company Information
13.6.2 Antares Pharma Self-administered Drugs Product Offered
13.6.3 Antares Pharma Self-administered Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Antares Pharma Main Business Overview
13.6.5 Antares Pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Self-administered Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Self-administered Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injectable Drugs
Table 4. Major Players of Inhaled Drugs
Table 5. Major Players of Transdermal Drugs
Table 6. Global Self-administered Drugs Sales by Type (2017-2022) & (K MT)
Table 7. Global Self-administered Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Self-administered Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Self-administered Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Self-administered Drugs Sale Price by Type (2017-2022) & (USD/MT)
Table 11. Global Self-administered Drugs Sales by Application (2017-2022) & (K MT)
Table 12. Global Self-administered Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Self-administered Drugs Revenue by Application (2017-2022)
Table 14. Global Self-administered Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Self-administered Drugs Sale Price by Application (2017-2022) & (USD/MT)
Table 16. Global Self-administered Drugs Sales by Company (2020-2022) & (K MT)
Table 17. Global Self-administered Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Self-administered Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Self-administered Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Self-administered Drugs Sale Price by Company (2020-2022) & (USD/MT)
Table 21. Key Manufacturers Self-administered Drugs Producing Area Distribution and Sales Area
Table 22. Players Self-administered Drugs Products Offered
Table 23. Self-administered Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Self-administered Drugs Sales by Geographic Region (2017-2022) & (K MT)
Table 27. Global Self-administered Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Self-administered Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Self-administered Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Self-administered Drugs Sales by Country/Region (2017-2022) & (K MT)
Table 31. Global Self-administered Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Self-administered Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Self-administered Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Self-administered Drugs Sales by Country (2017-2022) & (K MT)
Table 35. Americas Self-administered Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Self-administered Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Self-administered Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Self-administered Drugs Sales by Type (2017-2022) & (K MT)
Table 39. Americas Self-administered Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Self-administered Drugs Sales by Application (2017-2022) & (K MT)
Table 41. Americas Self-administered Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Self-administered Drugs Sales by Region (2017-2022) & (K MT)
Table 43. APAC Self-administered Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Self-administered Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Self-administered Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Self-administered Drugs Sales by Type (2017-2022) & (K MT)
Table 47. APAC Self-administered Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Self-administered Drugs Sales by Application (2017-2022) & (K MT)
Table 49. APAC Self-administered Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Self-administered Drugs Sales by Country (2017-2022) & (K MT)
Table 51. Europe Self-administered Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Self-administered Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Self-administered Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Self-administered Drugs Sales by Type (2017-2022) & (K MT)
Table 55. Europe Self-administered Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Self-administered Drugs Sales by Application (2017-2022) & (K MT)
Table 57. Europe Self-administered Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Self-administered Drugs Sales by Country (2017-2022) & (K MT)
Table 59. Middle East & Africa Self-administered Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Self-administered Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Self-administered Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Self-administered Drugs Sales by Type (2017-2022) & (K MT)
Table 63. Middle East & Africa Self-administered Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Self-administered Drugs Sales by Application (2017-2022) & (K MT)
Table 65. Middle East & Africa Self-administered Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Self-administered Drugs
Table 67. Key Market Challenges & Risks of Self-administered Drugs
Table 68. Key Industry Trends of Self-administered Drugs
Table 69. Self-administered Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Self-administered Drugs Distributors List
Table 72. Self-administered Drugs Customer List
Table 73. Global Self-administered Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 74. Global Self-administered Drugs Sales Market Forecast by Region
Table 75. Global Self-administered Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Self-administered Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Self-administered Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 78. Americas Self-administered Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Self-administered Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 80. APAC Self-administered Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Self-administered Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 82. Europe Self-administered Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Self-administered Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 84. Middle East & Africa Self-administered Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Self-administered Drugs Sales Forecast by Type (2023-2028) & (K MT)
Table 86. Global Self-administered Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Self-administered Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Self-administered Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Self-administered Drugs Sales Forecast by Application (2023-2028) & (K MT)
Table 90. Global Self-administered Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Self-administered Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Self-administered Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Abbott Laboratories Basic Information, Self-administered Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Abbott Laboratories Self-administered Drugs Product Offered
Table 95. Abbott Laboratories Self-administered Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 96. Abbott Laboratories Main Business
Table 97. Abbott Laboratories Latest Developments
Table 98. Bristol-Myers Squibb Basic Information, Self-administered Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Bristol-Myers Squibb Self-administered Drugs Product Offered
Table 100. Bristol-Myers Squibb Self-administered Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 101. Bristol-Myers Squibb Main Business
Table 102. Bristol-Myers Squibb Latest Developments
Table 103. Novartis AG Basic Information, Self-administered Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis AG Self-administered Drugs Product Offered
Table 105. Novartis AG Self-administered Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 106. Novartis AG Main Business
Table 107. Novartis AG Latest Developments
Table 108. Eli Lilly and Company Basic Information, Self-administered Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Eli Lilly and Company Self-administered Drugs Product Offered
Table 110. Eli Lilly and Company Self-administered Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 111. Eli Lilly and Company Main Business
Table 112. Eli Lilly and Company Latest Developments
Table 113. Gilead Sciences Basic Information, Self-administered Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Gilead Sciences Self-administered Drugs Product Offered
Table 115. Gilead Sciences Self-administered Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 116. Gilead Sciences Main Business
Table 117. Gilead Sciences Latest Developments
Table 118. Antares Pharma Basic Information, Self-administered Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Antares Pharma Self-administered Drugs Product Offered
Table 120. Antares Pharma Self-administered Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 121. Antares Pharma Main Business
Table 122. Antares Pharma Latest Developments
List of Figures
Figure 1. Picture of Self-administered Drugs
Figure 2. Self-administered Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Self-administered Drugs Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Self-administered Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Self-administered Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injectable Drugs
Figure 10. Product Picture of Inhaled Drugs
Figure 11. Product Picture of Transdermal Drugs
Figure 12. Global Self-administered Drugs Sales Market Share by Type in 2021
Figure 13. Global Self-administered Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Self-administered Drugs Consumed in Cardiovascular Diseases
Figure 15. Global Self-administered Drugs Market: Cardiovascular Diseases (2017-2022) & (K MT)
Figure 16. Self-administered Drugs Consumed in Diabetes
Figure 17. Global Self-administered Drugs Market: Diabetes (2017-2022) & (K MT)
Figure 18. Self-administered Drugs Consumed in Osteoporosis
Figure 19. Global Self-administered Drugs Market: Osteoporosis (2017-2022) & (K MT)
Figure 20. Self-administered Drugs Consumed in Pain Management
Figure 21. Global Self-administered Drugs Market: Pain Management (2017-2022) & (K MT)
Figure 22. Self-administered Drugs Consumed in Hormone Replacement
Figure 23. Global Self-administered Drugs Market: Hormone Replacement (2017-2022) & (K MT)
Figure 24. Self-administered Drugs Consumed in Others
Figure 25. Global Self-administered Drugs Market: Others (2017-2022) & (K MT)
Figure 26. Global Self-administered Drugs Sales Market Share by Application (2017-2022)
Figure 27. Global Self-administered Drugs Revenue Market Share by Application in 2021
Figure 28. Self-administered Drugs Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Self-administered Drugs Revenue Market Share by Company in 2021
Figure 30. Global Self-administered Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Self-administered Drugs Revenue Market Share by Geographic Region in 2021
Figure 32. Global Self-administered Drugs Sales Market Share by Region (2017-2022)
Figure 33. Global Self-administered Drugs Revenue Market Share by Country/Region in 2021
Figure 34. Americas Self-administered Drugs Sales 2017-2022 (K MT)
Figure 35. Americas Self-administered Drugs Revenue 2017-2022 ($ Millions)
Figure 36. APAC Self-administered Drugs Sales 2017-2022 (K MT)
Figure 37. APAC Self-administered Drugs Revenue 2017-2022 ($ Millions)
Figure 38. Europe Self-administered Drugs Sales 2017-2022 (K MT)
Figure 39. Europe Self-administered Drugs Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Self-administered Drugs Sales 2017-2022 (K MT)
Figure 41. Middle East & Africa Self-administered Drugs Revenue 2017-2022 ($ Millions)
Figure 42. Americas Self-administered Drugs Sales Market Share by Country in 2021
Figure 43. Americas Self-administered Drugs Revenue Market Share by Country in 2021
Figure 44. United States Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Self-administered Drugs Sales Market Share by Region in 2021
Figure 49. APAC Self-administered Drugs Revenue Market Share by Regions in 2021
Figure 50. China Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Self-administered Drugs Sales Market Share by Country in 2021
Figure 57. Europe Self-administered Drugs Revenue Market Share by Country in 2021
Figure 58. Germany Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Self-administered Drugs Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Self-administered Drugs Revenue Market Share by Country in 2021
Figure 65. Egypt Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Self-administered Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Self-administered Drugs in 2021
Figure 71. Manufacturing Process Analysis of Self-administered Drugs
Figure 72. Industry Chain Structure of Self-administered Drugs
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...